Skip to main content
. Author manuscript; available in PMC: 2022 Apr 8.
Published in final edited form as: Vaccine. 2021 Mar 18;39(15):2068–2073. doi: 10.1016/j.vaccine.2021.03.026

Table 3.

Adjusted prevalence ratios for characteristics associated with influenza vaccine coverage.

Age Adjusted PR (95% CI)
18 – 29 Reference
30 – 39 0.90 [0.78, 1.03]
40 – 49 0.68 [0.45, 1.03]
Race/Ethnicity
Non-Hispanic White Reference
Non-Hispamc Black 1.10 [0.87, 1.39]
Latina 0.88 [0.71, 1.10]
Other 0.69 [10.53, 0.90]**
Education
Less than HS Degree Reference
HS Degree of Equivalent 1.10 [0.79, 1.54]
College Degree 1.41 [0.99, 2.01]
Graduate School 1.52 [1.04, 2.23]*
Ratio of Income to FPL Thresholds
Less Than or Equal to 138% Reference
139% to 400% l.20 [0.95, 1.52]
Greater Than 400% l.54 [1.20, 1.96]**
Region
Northeast Reference
North Central/Midwest 0.99 [0.79, 1.24]
South 0.92 [0.75, 1.12]
West 1.05 [0.84 1.31]
Insurance Status
Uninsured Reference
Insured 1.90 [l.23, 2.93]**
Delayed Care Due to Cost
No Reference
Yes 0.79 [0.53, 1.18]
Co-Morbid Conditionsb
No Reference
Yes 0.93 [0.73. 1.18]
Survey Years
2012 – 2013 Reference
2014 1.13 [0.86, 1.49]
2015 – 2018 1.27 [1.08, 1.49]**

Data ate presented as adjusted prevalence ratios with 95% CI calculated with robust Poisson regression using survey weighted data. Data Source: National Health Interview Survey, 2012 to 2018.

***

p < 0.001

**

p < 0.01

*

p < 0.05.

a)

Includes Native Amencaa Asian. Multi Racial aisd Other.

b)

Defined as an asthma attack in the past 12 months, a diagnosis of hypertension (based on at least two provider visits), or diabetes requiring medications 'either insulin or oral medications).